v3.26.1
Summary of Significant Accounting Policies - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Numerator:        
Net income $ 36,560 $ 15,653 $ 47,976 $ 6,299
Less: Net loss attributable to noncontrolling interests 0 14 0 254
Net income attributable to Alignment Healthcare, Inc. $ 36,560 $ 15,667 $ 47,976 $ 6,553
Denominator:        
Total weighted-average common shares outstanding (in shares) 207,448,894 198,328,613 206,408,426 196,003,736
Less: Restricted shares of common stock (in shares) 0 0 0 (23,167)
Total weighted-average common shares outstanding, net of restricted shares of common stock - basic (in shares) 207,448,894 198,328,613 206,408,426 195,980,569
Dilutive effect of:        
Shares used to compute diluted income per common share (in shares) 215,024,483 209,519,629 214,369,175 201,576,078
Net income per share:        
Basic income per share (in dollars per share) $ 0.18 $ 0.08 $ 0.23 $ 0.03
Diluted income per share (in dollars per share) $ 0.17 $ 0.07 $ 0.22 $ 0.03
Stock options        
Dilutive effect of:        
Dilutive effect of common shares (in shares) 790,176 405,903 937,237 202,952
RSUs        
Dilutive effect of:        
Dilutive effect of common shares (in shares) 5,892,107 8,111,256 6,576,859 4,055,628
PSUs        
Dilutive effect of:        
Dilutive effect of common shares (in shares) 893,306 2,673,857 446,653 1,336,929